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Abstract
Background: Preoperative lymphoscintigraphy is one of the three methods of evaluating sentinel
nodes in patients with breast cancer; however, it has been reported to have a high false negative
rate.
Case presentations: We report here two cases where the preoperative lymphoscintigraphy was
found to be fallacious. A 44-year-old female with T2N0 breast cancer underwent preoperative
lymphoscintigraphy with Tc99 sulfur colloid which failed to show any uptake in axilla or internal
mammary chain. Intraoperative scintigraphy with blue dye and hand held gamma probe identified
sentinel lymph node in axilla. Another patient with T2N0 lesion underwent preoperative
lymphoscintigraphy which showed a sentinel lymph node in axilla and another in supraclevicular
fossa. Intraoperative scintigraphy failed to show supraclevicular node however axillary node was
correctly identified.
Conclusion: These two cases further strengthen the need to carry out triple test in identification
of sentinel lymph node in patients with breast cancer. It also demonstrates the fallacies of
preoperative lymphoscintigraphy.
Background
Metastasis to the axillary lymph node is the single most
important prognostic factor in breast cancer. The thera-
peutic decisions are based on the axillary status. However,
in recent past sentinel lymph node identification and
biopsy (SLNB) is fast emerging as an alternate to axillary
dissection as it avoids the complications of axillary dissec-
tion like lymphedema, pain, numbness and limitations of
shoulder movements [1,2]. SLNB has been found to be
highly predictive of axillary lymph node status with false
negative results of less than 5% [3-5]. A number of validity
studies have been published however, the question of its
oncological safety still awaits the results of randomized
clinical trials [6,7].
The sentinel lymph node identification is usually carried
out by preoperative localization using Tc99 colloid and
gamma camera or by intraoperative localization using
hand held gamma probe or by dye technique. Majority of
the centers use a combination of techniques and it has
been reported that the triple method using all of the above
gives the best results [8-10].
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Non-visualization of sentinel node at preoperative scin-
tigraphy is a continued problem. Between 3 to 30% of the
nodes are reported to be non visualized most of which are
subsequently picked up on intraoperative scintigraphy
[11-13]. Several factors like age, size of the breast, pres-
ence of metastasis, has been proposed to influence the
non-visualization [11-17]. We report here two unusual
cases of non-visualization or abnormal visualization dur-
ing preoperative lymphoscintigraphy; both of these cases
were subsequently identified and biopsied intraopera-
tively using a combination of blue dye and hand held
gamma probe.
Case presentation
Case 1
A 44-year-old female presented with 2 months history of
a progressive lump in right breast. She gave a past history
of noncyclic mastalgia of two years duration. There was no
other significant past history. Patient had undergone
abdominal hysterectomy 4 years back for dysfunction
uterine bleeding and was on hormone replacement ther-
apy with estrogen alone for the same duration.
On examination there was 4 × 3 cm lump in upper outer
quadrant of the right breast with no fixity to skin or under-
lying tissue. There were no significant axillary or supracla-
vicular nodes. Abdominal examination failed to show any
organomegaly. Routine hematological, biochemical tests,
chest roentgenogram, abdominal ultrasonogram and
bone scans were normal. Fine needle aspiration cytology
revealed Infiltrating duct carcinoma.
Patient was planned for sentinel lymph node biopsy fol-
low by mastectomy. 8 ml of Tc99  sulfur colloid was
injected around the tumor and immunoscintigraphy
images (anterior and lateral view) were taken. These
images failed to show any lymph node uptake either in
axilla or else where (figure 1) at the time of surgery 4 ml
of isosulfan blue was injected peritumorilly and 20 min-
utes later axilla was entered. Sentinel node detection was
also carried out using a hand held gamma probe (Naviga-
tor®, Auto sutures). Sentinel lymph node was identified by
combined technique in level I axilla lying just posterior to
the primary tumor. On gross examination most of the
node appeared to be replaced by tumor and only a part of
it appeared normal this part was stained blue while rest of
the node was white. Histopathology of primary tumors
was infiltrating duct carcinoma, with involvement of skin.
Sentinel lymph node showed metastatic deposit. Other
lymph nodes in axillary dissection specimen were also
positive.
Case 2
A 42-year-old female presented with lump in left breast of
1-month duration. She was a known case of carcinoma
breast and had undergone right modified radical mastec-
tomy 7 years back followed by chest wall radiotherapy
and 6 cycles of CMF chemotherapy.
On examination there was a 3 × 2 cm lump located in the
retro areolar area of left breast. Scar of right mastectomy
was seen. There were no palpable axillary nodes or supra
clavicular nodes. Systemic examination was normal. Rou-
tine hematological and biochemical investigations chest
x-ray, abdominal sonography and bone scans were nor-
mal. The treatment options were discuss with the patient
and she wanted to conserve this breast and hence a wide
excision of mass encompassing nipple areola complex,
sentinel node biopsy followed by axillary clearance was
planned.
On the morning of the surgery 4 ml of Tc99 sulfur colloid
was injected peritumorily and scintigraphic images were
taken 4 hours later. The scintigraphic image showed one
sentinel node in axilla and other in supra clavicular fossa
(figure 2). At surgery 4 ml of isosulfan blue was injected
peritumorilly and sentinel node identification was carried
out by combined method. On exploration of axilla the
blue and hot sentinel node was identified and removed.
However, hand held probe failed to pick a hot spot in
supra clavicular fossa axillary dissection was completed.
Histopathology of the resected specimen showed infiltra-
tive duct carcinoma margins of resection were negative.
Lymphoscientigraphic scan showing radioneucleotide uptake  in primary tumor, no sentinel node is identified Figure 1
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The sentinel node showed deposits from infiltrating duct
carcinoma. Post operative period was uneventful and it is
planned to start her on radiotherapy to residual breast
with 4 cycles of anthracyclin based chemotherapy.
Discussion
The axillary dissection for axillary nodes from breast can-
cer is still the standard of care its routine use in node neg-
ative breast cancer has been questioned due to morbidity
associated with the axillary dissection. SLNB has
improved the morbidity in patients with node negative
breast cancer, while providing the much needed prognos-
tic information. Although these techniques have been suc-
cessful, they are still evolving, and SLN biopsy is not yet
considered the standard of care in breast cancer.
Preoperative visualization is one of the three methods
commonly employed in detection of sentinel node. When
radioactive colloid is used, a preoperative lymphoscinti-
gram often is obtained to ease SLN identification further.
This has been reported to have a false negative rate of 3–
30% in various series [11-13]. Several factors like age, size
of the breast, presence of metastasis, neoadjuvant chemo-
therapy, has been proposed to influence the non-visuali-
zation [11-19]. Other authors have found no significant
predictor of non visualization [20]. The non-visualization
in our first case was due to superimposition of locally
advance tumor in the outer quadrant and hence separa-
tion was not achieved on scintigraphy, while the errone-
ous supra clavicular node in the other was probably due
to the spillage of radioactive material at the time of injec-
tion, which was subsequently washed off during the part
preparation and hence no signal was obtained at intraop-
erative gamma probe assisted SLNB.
Conclusion
These two cases demonstrate the importance of using the
triple technique to maximize the identification of SLN
and improve the sensitivity and specificity of SLNB and
fallacies of preoperative lymphoscintigraphy. This also
raises a question that should preoperative scintigraphy
should be carried out in all the cases?
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